Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelReplace CC RP 4.3x16mm: medical device reports filed with FDA

1,591 reports name it, 2019–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

1,591
device reports naming the brand
0% of all MAUDE reports · about 233 a year
232
reports, 12 months to August 2026
268 in the 12 months before
1.3%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,591 reports that name the brand "NobelReplace CC RP 4.3x16mm" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

232 reports arrived in the 12 months to August 2026, down 13% from 268 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.7%) and malfunction (1.3%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (68.3%), loss of osseointegration (21.3%) and osseointegration problem (6.8%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03876Sep 2021: 10Oct 2021: 3Nov 2021: 7Dec 2021: 332022Jan 2022: 19Feb 2022: 18Mar 2022: 37Apr 2022: 20May 2022: 11Jun 2022: 28Jul 2022: 26Aug 2022: 12Sep 2022: 12Oct 2022: 13Nov 2022: 12Dec 2022: 362023Jan 2023: 8Feb 2023: 21Mar 2023: 22Apr 2023: 40May 2023: 15Jun 2023: 9Jul 2023: 19Aug 2023: 37Sep 2023: 11Oct 2023: 18Nov 2023: 32Dec 2023: 312024Jan 2024: 23Feb 2024: 22Mar 2024: 9Apr 2024: 29May 2024: 15Jun 2024: 8Jul 2024: 14Aug 2024: 19Sep 2024: 24Oct 2024: 22Nov 2024: 24Dec 2024: 282025Jan 2025: 38Feb 2025: 12Mar 2025: 10Apr 2025: 10May 2025: 0Jun 2025: 2Jul 2025: 76Aug 2025: 22Sep 2025: 36Oct 2025: 22Nov 2025: 18Dec 2025: 122026Jan 2026: 6Feb 2026: 19Mar 2026: 8Apr 2026: 26May 2026: 24Jun 2026: 19Jul 2026: 24Aug 2026: 18

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01322632019: 9520192020: 14320202021: 20720212022: 24420222023: 26320232024: 23720242025: 25820252026: 1442026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.7%1,570
Malfunction1.3%21
Other0%0
Not given0%0

Who filed the report

Manufacturer report64.8%1,031
Voluntary report0%0
User facility report0%0
Distributor report35.2%560
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,08668.3%62.8%
Loss of osseointegration33921.3%22.4%
Osseointegration problem1086.8%7.7%
Fracturea broken bone171.1%1.6%
Patient device interaction problem70.4%0.3%
Migrationthe device moved from where it was placed40.3%0.1%
Separation failure40.3%0.1%
Insufficient device problem information20.1%0.2%
Material deformation20.1%0.1%
Activation, positioning or separation problem10.1%0%
Device markings/labelling problema problem with the device markings or label10.1%0%
Malposition of device10.1%0.1%
Premature separation10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,24178%
Painpain, site not specified1207.5%
Numbnessnumbness181.1%
Appropriate clinical signs, symptoms and conditions term/code not available140.9%
Inflammationinflammation40.3%
Bone fracture(s)20.1%
Sinus perforation10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelReplace CC RP 4.3x16mmProduct code DZEAll MAUDE reports
Reports1,5913,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.7%99.2%36.2%
Classified as malfunction1.3%0.8%62.3%
Filed by the manufacturer64.8%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelReplace CC RP 4.3x16mm reports

How many FDA reports name NobelReplace CC RP 4.3x16mm?

1,591 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 232 in the latest 12 months.

What kinds of events are reported?

injury (98.7%) and malfunction (1.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (68.3%), loss of osseointegration (21.3%), osseointegration problem (6.8%), fracture (1.1%) and patient device interaction problem (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (64.8%) and distributor reports (35.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelReplace CC RP 4.3x16mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.